Class action by businesses in the complementary medicines industry

We successfully defended a class action against five individual officers of the Therapeutic Goods Administration (TGA) worth in excess of $150 million. The class action was brought by 169 businesses in the complementary medicines industry who alleged substantial losses following the suspension by the TGA of the manufacturing licence of Pan Pharmaceuticals and subsequent recall of products. The litigation raised issues concerning the conduct of representative proceedings and involved a complex factual matrix which necessitated a labour intensive forensic factual investigation and assessment. A court-ordered mediation extending over four days resulted in a settlement of the action. The settlement was approved by the Federal Court of Australia. There was no finding nor concession of any wrongdoing by our clients. The compensation paid to the represented class of applicants was provided by the Commonwealth of Australia, which was the first respondent in the proceedings.


Related Articles

Brisbane decision demonstrates documented & compelling evidence crucial to assessment of psychological injury

Legal Directions

Introduction The plaintiff suffered personal injury at the Woodford Folk Festival on 1 January 2008 (the incident), when a stand with…

Continue reading

Non-employing entity found liable in negligence for criminal acts of a third person

Legal Directions

Wright by his tutor Wright v Optus Administration Pty Ltd [2015] NSWSC 160 At the time of preparing this article, we…

Continue reading

Are there any limitations on the operation of s54 of the Insurance Contracts Act?

Legal Directions

In Matthew Maxwell v Highway Hauliers Pty Ltd [2013] WASCA 115 the Court of Appeal of the Supreme Court of Western…

Continue reading